| Name
|
C-Peptide, Dog
|
| Other Name
|
|
| Sequence (Single letter abbreviations)
|
EVEDLQVRDVELAGAPGEGGLQPLALEGALQ
|
| Sequence（Three letter abbreviations）
|
{GLU}{VAL}{GLU}{ASP}{LEU}{GLN}{VAL}{ARG}{ASP}{VAL}{GLU}{LEU}{ALA}{GLY}{ALA}{PRO}{GLY}{GLU}{GLY}{GLY}{LEU}{GLN}{PRO}{LEU}{ALA}{LEU}{GLU}{GLY}{ALA}{LEU}{GLN}
|
| Basic description
|
The C-peptide of proinsulin is important for the biosynthesis of insulin but has for a long time been considered to be biologically inert. Data now indicates that C-peptide administration is accompanied by augmented blood flow in skeletal muscle and skin, diminished glomerular hyperfiltration, reduced urinary albumin excretion, and improved nerve function. The possibility exists that C-peptide replacement, together with insulin administration, may prevent the development or retard the progression of long-term complications in type 1 diabetes.
|
| The molecular weight
|
3174.490
|
| Chemical formula
|
C137H225N37O49
|
| The purity
|
> 95%
|
| Storage conditions
|
Store at -20°C.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
|
C-Peptide, Dog
